Recurrent IDH1/2 Mutated Glioma
1 clinical trials · Condition
◉ Watch Recurrent IDH1/2 Mutated Glioma
| Record | Firm | Date |
|---|---|---|
| Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation (NCT03666559) | Assistance Publique - Hôpitaux de Paris | 2020-09-22 |
Track Recurrent IDH1/2 Mutated Glioma automatically
Every clearance here is in the API, with alerts when new ones post.